This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Prestige Brands (PBH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LCUT vs. PBH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare (PBH) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) has been struggling lately, but the selling pressure may be coming to an end soon.
Central Garden & Pet (CENT) Solid on Buyouts & Digital Efforts
by Zacks Equity Research
Central Garden & Pet (CENT) banks on its robust business strategies. It is steadily advancing its digital capabilities and making wise acquisitions to boost growth.
LCUT vs. PBH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
Spectrum Brands (SPB) to Divest HHI to Focus on Core Units
by Zacks Equity Research
Spectrum Brands (SPB) agrees to sell off its HHI segment to effectively focus on its three core profitable units and strengthen its balance sheet.
Prestige Consumer (PBH) Surges More Than 65% YTD: Here's Why
by Zacks Equity Research
Prestige Consumer (PBH) is consistently making multi-year e-commerce investments, which are yielding well. The company is focusing on the areas with significant prospects, such as healthcare.
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
Earnings Estimates Rising for Prestige Brands (PBH): Will It Gain?
by Zacks Equity Research
Prestige Brands (PBH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Top Ranked Momentum Stocks to Buy for August 31st
by Zacks Equity Research
MOV, AAWW, PBH, and FCBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 31, 2021.
Consumer Spending, Personal Income Continue to Rise: 5 Picks
by Ritujay Ghosh
The rise in consumer confidence in July proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks like RICK, ALTO, PRTY, LCUT and PBH.
LCUT or PBH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
LCUT vs. PBH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LCUT vs. PBH: Which Stock Is the Better Value Option?
Prestige Consumer (PBH) Beats Q1 Earnings & Revenue Estimates
by Zacks Equity Research
Prestige Consumer's (PBH) Q1 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.
Prestige Brands (PBH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 32.56% and 15.17%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer (PBH) Queued for Q1 Earnings: Things to Note
by Zacks Equity Research
Prestige Consumer's (PBH) first-quarter fiscal 2022 performance is likely to reflect gains from strong e-commerce and brand-building efforts.
Prestige Brands (PBH) Reports Next Week: What to Expect
by Zacks Equity Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Consumer (PBH) Adds TheraTears to Its Eye Care Portfolio
by Zacks Equity Research
Prestige Consumer (PBH) expanded its eye care portfolio by acquiring TheraTears and four other brands across the VMS and Cough & Cold categories.
Prestige Consumer (PBH) Looks Poised on E-Commerce Strength
by Zacks Equity Research
Prestige Consumer's (PBH) solid e-commerce initiatives, together with its impressive marketing efforts and diverse brands, keep it well placed.
Prestige Consumer (PBH) Q4 Earnings Meet Estimates, Revenues Top
by Zacks Equity Research
Prestige Consumer's (PBH) fourth-quarter fiscal 2021 results reflect lower earnings and sales year over year due to pandemic-led disruptions in certain brands and tough comparisons with the year-ago period.
Prestige Brands (PBH) Q4 Earnings Match Estimates
by Zacks Equity Research
Prestige Brands (PBH) delivered earnings and revenue surprises of 0.00% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Know Ahead of Prestige Consumer (PBH) Q4 Earnings
by Zacks Equity Research
Lower consumption patterns across certain categories and tough year-over-year comparisons might have hurt Prestige Consumer's (PBH) fourth-quarter fiscal 2021 performance.
Earnings Preview: Prestige Brands (PBH) Q4 Earnings Expected to Decline
by Zacks Equity Research
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Prestige Consumer Healthcare (PBH) Looks Promising
by Zacks Equity Research
Prestige Consumer Healthcare (PBH) has been benefiting from a strong e-commerce performance as well as efficient saving efforts.
Consumer Confidence Soars to One-Year High in March: 5 Picks
by Ritujay Ghosh
The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, VSTO, SPB, SWBI, MBUU.